Showing posts with label DFATD. Show all posts
Showing posts with label DFATD. Show all posts

Monday, July 20, 2015

IPPF - Menstrual Regulation or Erratic Regulation?

We know that the $6 million DFATD gave IPPF for the Maternal, newborn and child health initiative wasn't to be used for abortion or menstrual regulation services.

(Note that MR is an abortion only if the woman is pregnant; so not all MR's amount to abortions. Because they don't check whether the woman is pregnant first, laws that ban abortions can be circumvented, since they don't actually know that she is pregnant. But if she is pregnant, then MR is an abortion.)

We also know Canadians are forced to simply take IPPF's word that this money is not being used for abortion or menstrual regulation services. See here and here. That's because IPPF says they aren't using the funding for abortion services, but there is no third party corroboration of this fact.

My latest ATIP to DFATD has again raised the MR question. This time the evidence is even more questionable.

On June 9, 2014, IPPF sent a report to DFATD detailing the services it provided in the five countries. Under the heading GYNECOLOGY - MANAGEMENT - MEDICAL, was the following line item:
"Gynecology - Management - Medical -Menstrual Regulation 9,800 [services]"
It seems that DFATD asked to IPPF to clarify this. There were a few emails from IPPF on this, and finally we get IPPF's conclusion of their investigation.
"Dear Anne, 
Per [name blacked out] previous email, attached I am sending you a revised table (originally submitted on 9 June 2014) showing the breakdown of 2013 gynaecological service data. With this email, I re-confirm that all the services that have been previously reported have been undertaken with funding from the DFATD project. The only revision has been that the services previously reported as `Menstrual Regulation' are now reported under `Erratic Regulation'. (emphasis added)
After consulting back with each of the MAs that had initially reported services under `Menstrual Regulation' we found that these have been miscategorised and no menstrual regulation services had in fact been offered. The MAs in Afghanistan and Sudan, who had originally reported' menstrual regulation services in 2013, had actually provided `Erratic regulation' (i.e. of menstruation) services. The IPPF service statistics module definition for the `Erratic regulation' service is: `A trained service provider provides management for menstrual irregularities such as heavy or painful periods with medication (such as oestrogens) when this is not contraindicated, for clients experiencing abnormally heavy or irregular periods, in a space which allows confidentiality.'  (emphasis added)
These services have now been correctly re-categorised. There are therefore no menstrual regulation services recorded for any of the 5 MAs in the DFATD project and the revised table with the breakdown of 2013's gynaecological services now displays the correct category. 
I am happy to go over this information with you over the phone if it would be helpful. 
With Warm Regards,
[name blacked out]"
So I looked up "erratic regulation", first on IPPF's site. No such definition exists there. Then I Googled "erratic regulation". I did find some definitions, but none of them relate to a anything gynecological and I could find nothing to indicate that this is a bona fide gynecological treatment.

As expected, Menstrual regulation was on IPPF's website:
"Evacuation of the uterus of a woman who has missed her menstrual period by 14 days or fewer, who previously had regular periods and who has been at risk of conception. In some countries menstrual regulation is legal, even though therapeutic abortion is not."
The corrected document IPPF sent to DFATD reads:
"Gynecology - Management - Medical - Erratic Regulation 9,800 [services]"  
So what exactly is going on here?
---------------------------------------------------------------------------------------------------------
Letter from IPPF to DFATD:

 Original submission from IPPF to DFATD


 Corrected submission from IPPF to DFATD:

Monday, February 16, 2015

IPPF and Depo-Provera: what about informed consent?

When we inject harmful drugs into the arms of poor women in Afghanistan, Bangladesh, Mali, Sudan, and Tanzania, do we tell them of the drug's serious side effects?

I'm talking about the contraceptive Depo-Provera. (revealed through an access to information request to DFATD on the $6 million funding to IPPF for the Maternal, Newborn, and Child Health initiative)

IPPF (through DFATD) purchased 18,000 units of this drug in one year (2013-2014), and injected over a half million shots of it into these women since 2012. (1)

So what are the drug's side effects?

Depo-Provera doubles the risk of breast cancer in women (2), causes severe bone loss forcing Pfizer to put a black box warning (3) on the drug. The drug also has horrible side effects for women coming off the drug, as reported by women themselves. (4)

Are we telling them of these risks? What about informed consent (5)? Laura Shea of the Women's Health Network wrote a 22 page paper on this drug. She discusses Bone Density loss, and the other side effects. She also comments on its use in developing countries.
"Many women’s groups have opposed the use of injectable contraceptives like Depo Provera in developing countries because Depo Provera poses particular health concerns for poor women, who may have low bone density due to poor nutritional status. These women are already vulnerable because access to local health care facilities is often inadequate or non-existent, and the right to informed consent is often overlooked..."
And just last month we learned that Depo-Provera is linked to a 40% higher risk of HIV.

So what is Canada doing about this? We team up with the Bill and Melinda Gates Foundation, who also provides Depo-Provera to poor countries. (7)

One of the mantras repeated over and over again throughout the hundreds of pages of documentation I've received from DFATD on the IPPF funding, is how IPPF is helping "remote, under-served, poor, and vulnerable populations" in these countries.

Really?

Does IPPF inform these women of the very serious side effects of these drugs? Do they explain the risks in the women's own language? Do these women benefit in any way from informed consent?

I couldn't find any references in the mountain of documentation I received, that referred to informed consent in any way. Yet IPPF tells us they are helping "remote, under-served, poor, and vulnerable populations". With Canadian money.

(1)  

(2) A study of Depo-Provera
"found that for women between 20 to 44 Years of Age, continued use for 12 months or longer was associated with a 2.2-fold [95% confidence interval (CI), 1.2–4.2] increased risk of invasive breast cancer."
"Women who use Depo-Provera Contraceptive Injection may lose significant bone mineral density. Bone loss is greater with increasing duration of use and may not be completely reversible. It is unknown if use of Depo-Provera Contraceptive Injection during adolescence or early adulthood, a critical period of bone accretion, will reduce peak bone mass and increase the risk of osteoporotic fracture in later life. Depo-Provera Contraceptive Injection should be used as a long-term birth control method (eg, longer than 2 years) only if other birth control methods are inadequate (see WARNINGS)."


Side effects as reported by women themselves (682 comments)

Adolescents and Young Women? (From a paper written by Laura Wershler for Canadian Woman Studies in 2005)
"One acknowledged outcome of Depo-Provera use is the time delay (three to 18 months or longer) after the last shot for a full return to fertility. This recovery time can be, for some women, fraught with distressing health problems for which no apparent treatment protocol exists. Weight gain is extremely common and more extreme in teenagers than adult women. Many women discontinue the drug for this reason. The depressive effects of DepoProvera are well known. Severe depression, anxiety, and paranoia have all been reported. Some women experience symptoms while on it, others experience depression after stopping the drug. Hot flashes, vaginal dryness, and other menopausal symptoms experienced by some women are directly due to the "bottomed-out levels of estrogen and testosterone" (Rako 1 10) that are also responsible for loss of bone density. Loss of desire for sex and loss of sexual sensitivity are also subsequent to hormonal depletion. Herein lays the irony of DepoProvera use by young women. The drug induces the hormonal profile of a menopausal woman and with it the potential to experience the full constellation of symptoms (once thought to be all in women's heads) that can so diminish the quality of life for women in mid-life and beyond. As a contraceptive choice for teenagers and young women, DepoProvera provides them the opportunity to experience loss of libido, vaginal dryness, unmanageable weight gain, depression, bone loss and other unpleasant outcomes in exchange for pregnancy prevention. These negative side-effects cause many women to stop using the drug, but others tolerate them, often not aware their symptoms are related to their choice of contraceptive. The other irony? Women who tolerate Depo-Provera best are most likely to take it long-term and, therefore, are most at risk for significant and potentially irreversible bone loss... "

(5) Reflections on Depo Provera: Contributions to Improving Drug Regulation in Canada 
"International use as a population control measure 
Historically, family planning programmes typically limited contraceptive choice to those methods that resulted in either: 1) permanent sterilization, or; 2) temporary sterilization as in the case of Depo Provera. Even before its approval as a contraceptive, Depo Provera was promoted by family planning programmes and population control agencies, predominantly in the so-called “developing” countries, because it was identified as a highly effective, provider-controlled technology that promised to drive down birth rates among poor women. Many women’s groups have opposed the use of injectable contraceptives like Depo Provera in developing countries because Depo Provera poses particular health concerns for poor women, who may have low bone density due to poor nutritional status. These women are already vulnerable because access to local health care facilities is often inadequate or non-existent, and the right to informed consent is often overlooked..." (emphasis mine)
(6) Depo-Provera Linked to Higher HIV Risk Researchers Find 
"Depo-Provera is associated with an increased risk of HIV infection in women, according to a review of research in Africa.
Women who receive the so-called “birth control shot” have about 40 percent higher odds of becoming infected with HIV, compared to women using some other form of birth control or no birth control at all, researchers reported."
(7) The Globe speaks to Stephen Harper and Melinda Gates about maternal and child health
"...And Mr. Harper, do you see that the same way, that reproductive health needs to be a part of the initiative? 
[Stephen Harper] Yes, there’s actually a myth that we don’t fund any family planning or maternal health. That’s not true. We do. We, specifically as a result of a vote in Parliament do not fund abortion services but we fund other forms. And yes, I do happen to believe that’s an essential part of the continuum."

Friday, December 12, 2014

IPPF: 45 million services, but no abortion?

You may recall that the $6 million funding Canada gave to IPPF through DFATD for Afghanistan, Bangladesh, Mali, Sudan and Tanzania, was not to go for abortion services.

In fact, in the ATIP document I received from DFATD, there are multiple assurances from IPPF that the money is not being used for abortion services.Yet all we really have is IPPF's word for it.

Below I have summarized all the services provided by IPPF in fiscal year 2013/2014.

As you can see, that's a lot of services, yet many are not at all well defined.

So I asked for some clarifications on some of these services.

For item 1128 (Provide other SRH medical services) which had 1,798,317 services, I asked for a further breakdown of what these services were.

DFATD response:
"Consultation - Bangladesh, Mali
Diagnostic tests - Bangladesh, Mali,Tanzania
Therapy/treatment - Bangladesh, Afghanistan
Surgery - Bangladesh, Tanzania
Other - Bangladesh, Tanzania, Sudan"
As you can see these breakdowns still don't tell us what kinds of services IPPF is providing. So I asked for an additional clarification.

DFATD response:
"IPPF does not have additional description for these services, but it should be noted that these services do not relate to HIV, STI, abortion, gynaecology, obstetrics, etc."
So IPPF has no idea what exactly, these almost 2 million services include--yet we are simply expected to take IPPF's word for it that they don't include abortion?

Then for item 1211 (Other family planning services for young people), of which there were 4,860,975 services, I asked for a description of each of these "family planning services" and their breakdown by numbers, for each different category of service.

DFATD response:
"All family planning services are provided to young people. Essentially the same methods as the other FP indicators, for clients under 25. No information about how DFATD funding relates to this."
I then asked DFATD, if IPPF is saying that they do not know how much DFATD money goes to giving FP services to young people?

DFATD's response:
"IPPF does not price consultations or staff member’s time - by either age group or service category, therefore they cannot earmark a specific amount for what was spent on youth family planning services. IPPF estimates the cash value based on salaries and clinic space as they are the two key drivers of price."
So IPPF provided almost 5 million services to young people, with no further breakdown. Again we just have to take IPPF's word for it. And what is the ages of these young people?

DFATD's response:
"Member Associations (IPPF's local partners) abide by the legal limits in the country it operates."
And what are the legal age limits in these countries? I'm waiting for an answer to that.

But there in a nutshell, is the real problem with all this. The Canadian people give their tax dollars to DFATD. DFATD then gives that money to IPPF. IPPF then gives that money to its "member associations" to provide in most cases--undefined services.

If IPPF can't break down these services any further (and they can't), then how do they know the member associations are not using the money for abortion? Do we just have to take their word for it? Apparently.


Tuesday, October 7, 2014

Government of Bangladesh dismisses board of FPAB

Two more interesting things from my recent ATIP to DFATD and the $6 million grant to IPPF.

1) FPAB is the Family Planning Association of Bangladesh. In other words, FPAB is IPPF's member association in that country

Apparently the entire FPAB board was dismissed by the Bangladesh government.

DFATD refers to page 5 of the semi-annual report (ATIP page 67), which I also had from my last ATIP. (See ATIP page 119 below).

This is what DFATD asked in their question to IPPF:
"Could you provide some information about why the Government of Bangladesh dismissed FPAB's Board in August? Also, I don't know if you informed DFATD about this when it happened. However, this is the sort of thing we should know about when it happens, so that we are able to respond to any questions that may arise."

I looked at page 5 of the semi-annual report (from my previous ATIP) to see what IPPF reported there (see below ATIP page numbers 66 and 67. I also include page 66 for context). Well that part of the ATIP is blacked out on the semi-annual report.

So what does IPPF respond to DFATD's question? I don't know, because that paragraph is completely blanked out citing s.21(1)(b) of the Access to Information Act*. Which mean we have no idea, why the Government of Bangladesh dismissed the entire board, of an organization that operates on IPPF's behalf, using dollars from Canadian tax payers.

2) Note this question from DFATD to IPPF, and IPPF's response, also on page 119:
"DFATD: In addition, I would be curious to know how IPPF CO monitors project activities. Much of the report seems to be based on the self-reporting of the MAs. While I have no reason to doubt their reports, given the level of interest in the project, it would be helpful to learn how you track progress on the less quantitative aspects of the project. (emphasis mine)
IPPF: Regional Technical Officers are in regular communication with Member Associations (MA), and take regular visits to each MA to monitor their activities and progress. It is during these visits that the more qualitative aspects of the project are monitored and reviewed. In turn, Regional Technical Officers are also in regular contact with the Access Team in the Central Office to ensure MA. activities are in compliance with IPPF technical guidelines as well as IPPF's Strategic Framework.

"Self reporting" of member associations. I find this a bit worrisome. Especially when the entire board of one of those organizations has been dismissed and we don't know why.




* s.21(1)(b) The head of a government institution may refuse to disclose any record requested under this Act that contains...an account of consultations or deliberations in which directors, officers or employees of a government institution, a minister of the Crown or the staff of a minister participate

Tuesday, September 23, 2014

DFATD and IPPF - purchased and provided are different

More on my DFATD ATIP for the $6 million funding to International Planned Parenthood.

Suzanne asked who is using all this contraception, and wondered about the 15000 IUDs? So I decided to review the numbers to find out.

Below are the list of "Commodities and Clinical Consumables" (purchases) and the "Data Table" report (provided). Both reports are for the year 1 April 2013 to 31 March 2014. The numbers are different.

This is what was purchased:
IUDs listed under "Commodities and Clinical Consumables":
Afghanistan: 15,000
Bangladesh: 0
Mali: 2,500
Sudan: 0
Tanzania: 0
Total: 17,250

And this is what was provided:
IUDs listed under "Data Table":
Afghanistan: 11,299
Bangladesh: 4,221
Mali: 1,366
Sudan: 1,104
Tanzania: 1,671
Total: 19,661

----------------
This is what was purchased:
Condoms listed under "Commodities and Clinical Consumables":
Afghanistan: 290,000
Bangladesh: 0
Mali: 1,132,587
Sudan: 0
Tanzania: 0
Total: 1,447,787

And this is what was provided:
Condoms listed under "Data Table":
Afghanistan: 22,370
Bangladesh: 530,452
Mali: 224,588
Sudan: 1,653
Tanzania: 92,007
Total: 871,070 (the total on the Data Table report actually says 868,241)






These two tables are the "Data Tables" from the report



Monday, September 22, 2014

DFATD and IPPF - check your numbers

More on my DFATD ATIP for the $6 million funding to International Planned Parenthood.

I received a list of commodities and clinical consumables for the period 1 April 2013 - March 2014 (12 month period), which included contraception, injectables, condoms, spermicides etc. I also received the same information for the previous semi-annual report for April -September 2013 (a six month period).

I decided to compare the two reports to see how the numbers had increased, since the first was for a full year and the latter for only six months. When I looked a bit closer at the two reports, I noticed something. The numbers on both reports for Afghanistan and Sudan were identical (below I reproduce the first page of Afghanistan's).

No commodities were purchased between October 2013 and March 2014 (since the numbers are identical). Maybe all items were purchased at the beginning of the year? I don't know.

In any event, how many contraceptives and emergency contraceptives are we buying in Afghanistan anyway? See charts below.

(NOTE: Postinor-2 is emergency contraception. EC is considered an abortifacient if the egg has already been fertilized (i.e it prevents implantation in the uterus, killing the embryo). Abortion is illegal in Afghanistan.)



DFATD and IPPF - 45,118 people not sterilized in Tanzania

I've finally received the results of my most recent ATIP to DFATD regarding the $6 million funding to International Planned Parenthood. 

This one asked for information since my last ATIP, in particular, for IPPF's Annual Report for 1 April 2013 - March 2014.

I have learned a couple of interesting things this time, and will post them over the next little while.

The first thing I learned is that the people of Tanzania may not be as enthralled with being sterilized as IPPF would like them to be.

On page 143 of the ATIP, from the Annual Report, on line item 1121 Provide sterilization services in Afghanistan, Bangladesh, Mali, Sudan and Tanzania note this:

The target sterilizations for the year is 63,455 sterilizations, but the actual is only 18,337 sterilizations. That's 45,118 people under target.

Under the comments section is this:
"The overall shortfall is almost entirely due to Tanzania. It has not been possible to ascertain why."

Could it be that the people of Tanzania don't want to be sterilized? Maybe they don't like having IPPF suggesting they should be sterilized. 


Saturday, May 31, 2014

Canada pays for emergency contraception and abortion care in Afghanistan

Elizabeth Payne reported in today's Ottawa Citizen on my posting that revealed that CIDA/DFATD is funding emergency contraception in Afghanistan through IPPF.

What she didn't say, is that my ATIP also revealed that we are funding "safe abortion care".

The first thing that's worrisome about the Citizen article, is that NDP international development critic  Hélène Laverdière thinks that the emergency contraception used (Postinor-2) is not abortion.
“It’s not abortion, it is contraception". 
In fact the information provided by the manufacturer says that:
"Postinor-2 is not intended as a regular method of contraception." 
That's because, emergency contraception is an abortifacient if the egg has already been fertilized (i.e it prevents implantation in the uterus, killing the embryo). Wishful thinking, doesn't make it true.

Then Ms. Laverdière says:
"I don’t see why if it is a choice for Canadian women, it cannot be a choice offered to Afghan women.”
Now this is really out there. Shouldn't Ms. Laverdière, in her role as international development critic, know that abortion (including emergency contraception) is illegal in Afghanistan?

As I noted in that blog posting, the Population Research Institute says that:
"The current Afghanistan abortion law mandates a seven-year prison term and a monetary fine for each abortion performed. The only exception requires the written opinion of physicians, and a judicial review. According to strict and clear guidelines promulgated by the Ministry of Justice, this same law would apply to anyone who has prescribed “morning-after pills” or “emergency contraception” in Afghanistan, or even to anyone carrying these devices in the country."
And finally this from DFATD in the Citizen article:
"Foreign Affairs spokeswoman Amy Mills, quoting the World Health Organization. “WHO confirms that: ‘Levonorgestrel emergency contraceptive pills are not effective once the process of implantation has begun, and they will not cause abortion,’ ” she wrote in an email, adding, “DFATD funds are not used to fund abortion.”
I beg to differ. Canada is funding emergency contraception and abortion care in Afghanistan.

Abortion by any other name...

Sunday, May 4, 2014

MP questions CIDA due diligence insuring IPPF isn't funding abortions

We now have more cause for concern regarding CIDA/DFATD's $6 million funding of IPPF.

In an ATIP to DFATD I asked for correspondence regarding the Muskoka initiative on maternal and child health.to the PMO and CIDA.

This yielded a few letters, but one in particular was noteworthy.

On October 27, 2011, in a very detailed letter from MP Maurice Vellacott to Stephen Harper, Mr. Vellacott voices his concerns to the Prime Minister by asking seven questions about the $6 million funding IPPF received as part of the Muskoka initiative. (see below for Mr. Vellacott's letter and the responses from Mr. Harper and Ms. Oda).

In a nutshell, Mr. Vellacott's questions what due diligence is in place to ensure the funding would not go to pay for any abortion services, as was stipulated by the contribution agreement between CIDA and IPPF. All pertinent questions I thought, some of which I've also asked myself to CIDA/DFATD. (For all my links to the CIDA/IPPF funding see this page.)

The Prime Minister doesn't answer any of Mr. Vellacott's questions. Not one. And then the PM simply forwards Mr. Vellacott's letter on, to then Minister Bev Oda, who also doesn't answer any of his questions. Not one. In fact Ms. Oda's reply is obviously a form letter, since it is exactly the same as all of her responses to the other letters in the package.

So why were Mr. Vellacott's questions never answered?







Friday, May 2, 2014

Canadian money to IPPF for funding "safe abortion care" and "emergency contraception" in Afghanistan

Despite assurances by the Federal government that no Canadian money given to IPPF would go towards abortion, my latest ATIP to CIDA/DFATD revealed that IPPF is buying "emergency contraception" (34,000 units of the Abbot drug Postinor -2 (Levonorgestrel)). They are also providing "safe abortion care" in Afghanistan.

As we know, "emergency contraception" is taken after sexual intercourse for the purpose of "preventing" pregnancy, but it functions as an abortifacient if fertilization has already occurred (it prevents implantation of the embryo, thus destroying the life of the newly conceived human being.)

(See below for page 30 from the IPPF Annual Report Year 2 (1 April 2012 - 31 March 2013) and page 88 from the IPPF Midyear Report (1 April to 30 September 2013).

In fact, according to this medical leaflet, Postinor-2 is only used as emergency contraception:
"Postinor-2 is an emergency contraceptive only. Postinor-2 is not intended as a regular method of contraception. It is used to prevent pregnancy when taken within 72 hours of unprotected intercourse. It is estimated that Postinor-2 will prevent 85% of expected pregnancies. 95% of expected pregnancies will be prevented if taken within the first 24 hours, declining to 58% if taken between 48 hours and 72 hours after unprotected intercourse."
Not only that. Apparently AFGA's abortion services "needs improvement." (Afghan Family Guidance Association is an associate member of International Planned Parenthood Federation (IPPF) and receives funding from IPPF).

Why is AFGA providing abortion care, when we aren't even supposed to be funding abortion services in these countries?

This is what the Population Research Institute says about the legality of abortion, and emergency contraception in Afghanistan:
"The current Afghanistan abortion law mandates a seven-year prison term and a monetary fine for each abortion performed. The only exception requires the written opinion of physicians, and a judicial review. According to strict and clear guidelines promulgated by the Ministry of Justice, this same law would apply to anyone who has prescribed “morning-after pills” or “emergency contraception” in Afghanistan, or even to anyone carrying these devices in the country."
IPPF states in their annual report that this funding is directed towards:
"women, girls, men and boys who need access to reproductive health services and information. Clients reached throughout this project are female, male, young and old, couples and families in five countries (Afghanistan, Bangladesh, Mali, Sudan and Tanzania). The project prioritizes vulnerable individuals and groups, and also young people, especially young women. Seventy per cent of all the clients served through the project are poor, marginalized, socially excluded and/or underserved, while 33% of all clients are young people, aged between 15-25 years."
Are these poor, marginalized and vulnerable young women, even told what emergency contraceptive is? That it doesn't necessarily prevent conception--i.e. that if fertilization (conception) has occurred, it destroys that newly conceived life by preventing implantation. In other words, are these poor, marginalized and vulnerable clients giving their informed consent?

By all accounts, this is a pretty clear indication to me, that we are providing abortion services in Afghanistan. Abortion services that are specifically excluded from the terms and conditions of the $6 million dollar grant we gave to IPPF.

This should cause us grave concern.



Thursday, April 10, 2014

PMO: Engaging citizens fosters trust

When Stephen Harper told us that Canada will host a summit on saving the lives of vulnerable women and children, I thought, good idea.

What would the obvious next question be that immediately springs to mind: Who will be attending the summit?

In other words, who are the "Canadian stakeholders, experts" and "global leaders from developed and developing countries, international organizations, civil society, the private sector, and foundations to take stock of the progress made to date and discuss the way forward" mentioned in the press release?

So I asked the Prime Minister's office this question. And in the interest of transparency--as I assume the summit will be funded by taxpayers--I thought I'd get some kind of substantive answer from the PMO.

What I was told was that:
"The list of participants of the summit will be made available in due course—all of the latest information will be updated immediately to www.pm.gc.ca  where you can access it."
Which prompted me to ask two more questions:

1) I'd also like to obtain information on the process that is being used for selecting invitees. How is that being accomplished? And what is the criteria for choosing an organization?

2) Also, what if I'd like to submit a name of an organization to be included in the summit? How can I go about doing that?

After a couple of more emails and phone calls to the PMO, I finally received my response from Carl Vallée. Short and sweet:
"We don't discuss internal process."
Don't we, as Canadian Citizens have a right to know who is being invited to discuss something as important as this summit obviously will be? After all, it is our money that will be funding the summit itself, never mind the actual aid to this initiative: a total of $7.3 billion from G8 and non-G8 countries, which includes Canada.

I think my questions are completely fair and reasonable and deserve an answer. In fact why would the PMO even tell us about this initiative, if they have no intention of answering questions about it, or giving us any additional information?

What about openness and transparency?

Monday, March 31, 2014

So how much has CIDA given IPPF anyway?

This is another fun fact from my recent ATIP to CIDA/DFATD.

The answer would be $147 million since 1983. That's about $5 million a year.

That's your tax dollars and mine. Given to the world's number one abortion provider.




Sunday, March 30, 2014

Jadelle not purchased for Tanzania - instead purchased for Mali

Remember Jadelle? Well it's back.

I recently received more information from CIDA/DFATD about the $6 million funding to IPPF.

In my current ATIP, it looks like my writing about Jadelle before (see page 181 below) triggered some questions from DFATD to IPPF, about Jadelle.

DFATD asked IPPF:
"Could you please provide us with more information on the contraceptives that your Tanzanian member uses as part of the project we fund?
The response (in part) from IPPF was that:
1. IPPF has not purchased Jadelle and distributed it to Tanzania
2. UMATI has not purchased Jadelle with Canadian funds
3. Canadian funds have not been used to ensure service providers and insert and remove Jadelle [sic] (see page 178 below)
Interesting. But what is even more interesting is that on another page located withing the semi-annual report, I discovered that Jadelle was purchased and used in Mali.

In the IPPF semi-annual report (April-September 2013) it was revealed that IPPF purchased a quantity of 4,000 Jadelle implants for Mali. On the same report, sure enough there is no Jadelle listed for Tanzania. (I'll post those pages later.)

(Update April 25, 2014, More information on this drug here
"Adverse health conditions among American women subsequent to Norplant use American women have experienced serious adverse health conditions after having Norplant inserted, including, but not limited to, increased intracranial fluid pressure (pseudo tumor cerebri), chronic blurred vision, leading to permanent vision loss or blindness, and tumors in the brain and other organs.2,3 Other conditions experienced by American women include hyper menorrhea (heavy and sustained menstrual bleeding), serious acne, sustained nausea, debilitating headaches, weakness or paralysis in one or more limbs, endometriosis, ovarian cysts, weight gains of sometimes over 100 pounds, severe mood swings and irritability. Further, many have found that having Norplant removed was a much more difficult procedure than they had been originally advised.4")





Note: On my last CIDA/DFATD ATIP, I had questioned them to find out specifically what was being funded under the "Approved Activities" (1) for the five countries Afghanistan, Mali, Tanzania, Bangladesh and Sudan. I was told that "no records related to your request exist." This time I received some of the details of that request. I'll blog more about that later.

Sunday, March 16, 2014

CIDA funding to IPPF - the series

Here are all my writings on the funding CIDA (now called DFATD or Foreign Affairs, Trade and Development Canada) has given to IPPF (International Planned Parenthood).

Monday, July 20, 2015
IPPF - Menstrual Regulation or Erratic Regulation?

Monday, February 16, 2015
IPPF and Depo-Provera: what about informed consent?

IPPF: 45 million services, but no abortion?
Friday, December 12, 2014

Government of Bangladesh dismisses board of FPAB
Tuesday, October 7, 2014

DFATD and IPPF - the numbers don't add up
September 23, 2014

DFATD and IPPF - check your numbers
September 22, 2014

DFATD and IPPF - 45,118 people not sterilized in Tanzania
September 22, 2014

---------------------------------------------------------------------------------
MP questions CIDA due diligence insuring IPPF isn't funding abortions
May 4, 2014

Canadian money to IPPF for funding "safe abortion care" and "emergency contraception" in Afghanistan
May 2, 2014

Dec 10, 2013, 2013 

Oct 15, 2013 

Oct 04, 2013 

Sep 28, 2013

Sep 14, 2013

Jan 23, 2012

Jan 23, 2012 

Jan 23, 2012 

Jan 21, 2012